Figure 5From: In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapySelection pressures driving the development of resistance. The selection pressures driving resistance in (A) systemic antiretroviral therapy, compared to (B) the bipartite distribution of gene therapy.Back to article page